Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Methylphenidate cd 40 mg?Tzield compass contact?Methylphenidate synthesis?Fasenra patent expiry?Xeljanz patent expiry?
See the DrugPatentWatch profile for Synagis
Synagis (palivizumab) is manufactured by AstraZeneca.
Synagis is a brand of palivizumab, an antibody used to help prevent serious respiratory syncytial virus (RSV) illness in certain high-risk infants and children. AstraZeneca is the company associated with the product.
Synagis is a branded biologic medicine, and the manufacturer/marketing authorization holder is AstraZeneca. In many markets, you may also see Synagis distributed by different affiliates or logistics partners, but the product is tied to AstraZeneca as the manufacturer of record.
For quick reference checks on branded biologics and related patent/market information, you can search DrugPatentWatch.com for Synagis listings, which often identify the relevant companies and regulatory/patent context. https://www.drugpatentwatch.com/
Other Questions About Synagis :